Bioinformatics Market Size, Share & Segmentation by Product & Services (Knowledge Management Tools, Bioinformatics Services, Bioinformatics Platforms), By Application (Genomics, Transcriptomics, Metabolomics, Chemoinformatics & Drug Design, Proteomics), and by Regions | Global Market Forecast 2023-2030

Report Scope & Overview:

The Bioinformatics Market Size was evaluated at USD 12.56 billion in 2022, and is predicted to increase at a CAGR of 15.5% from 2023 to 2030, to reach USD 38.79 billion.

The human genetic project and the sequencing programs of other organisms have created an unparalleled amount of biological data. The ever-changing science of bioinformatics manages to meet the great need for data analysis and translation. The use of computational and analytical tools in capturing and interpreting biological data is seen as bioinformatics. Computer science, mathematics, physics, and biology are all used in this multi-disciplinary guide. In modern biology and medicine, bioinformatics is important in data management. Bioinformatics is a branch of computer science that studies the sequence of molecular cells.

It is very good at looking at genes and other protein sequences and other patterns within the organism and between living organisms, looking at the links between evolution in animals, and finding out what patterns are seen across DNA and the sequence of proteins. Bioinformatics can be seen as part of genetic language. Bioinformatics techniques include cellular and chemical techniques in the search for natural materials.

The ability to perform complex tests and phylogenetic adjustments are also important features of molecular mechanisms. Genetic sequence analysis is needed to gain a better understanding of the genes or epigenetic components of various bacterial taxa. A growing number of fully-fledged microbial genomes, including those that are known producers of natural bacterial products, have shown that the genetic and metabolic potential of these microbes is much higher than previously expected.

MARKET DYNAMICS

DRIVERS

• Growing bioinformatics financing from the public and private sectors

• Personalized medicine is becoming more popular.

• R&D spending on pharmaceuticals and biotechnology is increasing.

• Costs of genomic sequencing are falling.

RESTRAINTS

• Equipment expenditures are high.

• Professionals in Short Supply

OPPORTUNITIES

• Developing business sectors offer worthwhile open doors

• Blockchain and distributed computing reception are on the ascent.

• Machine learning and artificial intelligence (AI) have been integrated into healthcare.

• Bioinformatics solutions are being developed with the help of prominent IT businesses.

CHALLENGES

• Managing massive amounts of data

• There is a scarcity of qualified bioinformatics professionals.

• Interoperability and multiplatform capacities are deficient.

• In-house improvement and freely accessible advances are turning out to be more serious.

IMPACT OF COVID-19

When it comes to giving critical support to various fields of scientific research, bioinformatics has always had tremendous potential. Bioinformatics was put to the test during the COVID-19 pandemic. During the COVID-19 pandemic, one of the key priority areas for each country was to research and understand ways to stop the virus's spread. The most basic method for studying SARS-CoV-2 genomes is next-generation sequencing, which provides basic information on the virus. For calculating such data and enhancing understanding of SARS-CoV-2, bioinformatics pipelines and biological and host-virus interaction databases are key tools. As a result, a variety of research are being conducted to better understand the virus's genetic composition, with bioinformatics as a driving force. Bioinformatics outsourcing has risen throughout the pandemic in this setting. Scientists were able to unearth several secrets of SARS-CoV-2, ranging from its detection to its origin (including its functioning and propagation), in a short period of time, thanks to the advanced and improved bioinformatics abilities of specialist co-ops.

Value Chain analysis

The market is dominated by North American regions, which have a high demand rate. It also controls a significant portion of the bioinformatics market. It is a region that accounts for almost 45 percent of the market. The significant demand is due to the presence of leading bioinformatics marketplaces.

In this region, government activities are constantly increasing. In this field, bioinformatics is advancing at a rapid pace. Furthermore, bioinformatics technology is extremely well-known in North America. In addition, it is a good location for future research. The market situation is constantly improving, with significant development potential.

By Product & Services

Bioinformatics Platforms, Knowledge Management Tools, and Bioinformatics Services are the three categories that the market is divided into. Because of an increase in platform applications and desire for better tools in drug development, the Bioinformatics Platforms sector was the top revenue producer in the market. During the forecast term, this pattern is predicted to persist. An increase in demand from life science businesses for structural identification and customization can be attributed to the development in platform applications. As a result, drug development and treatment impact evaluation would be aided. In addition, as drug research and development become more efficient and safer, the demand for new drug development technologies develops. As a result, the Global Bioinformatics Market is expected to expand.

By Application

Genomics was the most popular. The advent of technical innovations targeted at managing massive quantities of genomic data, as well as the growing demand for pharmacogenomics in drug discovery and sequence screening, are major factors accounting for this large percentage.

Proteomics has seen a lot of R&D, and bioinformatics plays a big part in understanding and managing the data that comes out of it. This also makes handling heterogeneous and massive data sets, introducing new methods, and improving the knowledge discovery process easier.

COMPETITIVE LANDSCAPE

Some of the major key players of Bioinformatics Market are as follows: Affymetrix, BIOVIA, Agilent Technologies, BioWisdom Ltd, Celera Corporation, IBM, Life Sciences, Illumina Inc., Life Technologies Corporation, 3rd Millennium Inc, and other players.

MARKET SEGMENTATION:

By Product & Services

• Knowledge Management Tools

• Bioinformatics Services

• Bioinformatics Platforms

By Application

• Genomics

• Transcriptomics

• Metabolomics

• Chemoinformatics & Drug Design

• Proteomics

REGIONAL ANALYSIS

The bioinformatics market was led by North America, Europe and Asia Pacific coming second and third. Government support for genomic research, availability of leading bioinformatics providers, low cost of follow-up, increased awareness of bioinformatics services, and increased number of genomic research activities (and concomitant adoption of bioinformatics) regional development-development bioinformatics in North America. The location of funding for research projects in North America is excellent. Increased government efforts to reimburse genomic testing and the willingness to fund bioinformatics research activities reflect this regional market.

REGIONAL COVERAGE:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Rest of Europe
• Asia-Pacific
  • Japan
  • south Korea
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
• The Middle East & Africa
  • Israel
  • UAE
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Frequently Asked Questions (FAQ) :